Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/oxford-university-press/epidemiology-of-hepatitis-c-virus-in-europe-kRLjhJeAzz
References (6)
-
T. Stroffolini, M. Chiaramonte, C. Tiribelli, E. Villa, R. Simonetti, M. Rapicetta, M. Stazi, T. Bertin, S. Croce’, P. Trande, A. Magliocco, P. Chionne (1992)
Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.Journal of hepatology, 16 3
-
A. Alberti, G. Morsica, L. Chemello, D. Cavalletto, F. Noventa, P. Pontisso, A. Ruol (1992)
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCVThe Lancet, 340
-
M. Colombo, R. Franchis, E. Ninno, A. Sangiovanni, C. Fazio, M. Tommasini, M. Donato, A. Piva, V. Carlo, N. Dioguardi (1991)
Hepatocellular carcinoma in Italian patients with cirrhosis.The New England journal of medicine, 325 10
-
A. Zanetti, E. Tanzi, M. Newell (1999)
Mother-to-infant transmission of hepatitis C virus.Journal of hepatology, 31 Suppl 1
-
S. Brillanti, M. Foli, S. Gaiani, C. Masci, M. Miglioli, Luigi Barbara (1993)
Persistent hepatitis C viraemia without liver diseaseThe Lancet, 341
-
N. Caporaso, Marco Romano, R. Marmo, I. Sio, F. Morisco, A. Minerva, M. Coltorti (1991)
Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis.Journal of hepatology, 12 3
- Publisher
- Oxford University Press
- Copyright
- © 1994 Federation of European Microbiological Societies
- ISSN
- 0168-6445
- eISSN
- 1574-6976
- DOI
- 10.1111/j.1574-6976.1994.tb00098.x
- pmid
- 7522025
- Publisher site
- See Article on Publisher Site
Abstract
AbstractEpidemiology of Hepatitis C virus (HCV) infection in Europe is changing very rapidly since the main source of contamination was blood transfusion and the use of surrogate markers allowed to diminish dramatically the number of patients contaminated through HCV post transfusion hepatitis. The recent descrition of several genotypes with different distributions over Europe and different pathogenicity will allow to explain various evolutive aspects of disease. At present, groups at risk are drug addicts (70%), hemophiliacs (contaminated with blood products before 1985), hemodialysis patients (20%) and patients with cirrhosis with or without hepatocellular carcinoma. The detection of HCV markers prior to blood transfusion allowed to detect asymptomatic carrirers of HCV, some of them with latent chronic hepatitis which can be predictedby the detection of HCV RNA in the serum. Vertical and sexual transmision are rare but possible event observed with certainty in patients co-infected with HIV and controversial in other situations.
Journal
FEMS Microbiology Reviews – Oxford University Press
Published: Jul 1, 1994